Kevin C Wang

Title: Kevin C Wang: Innovator in Neurobiology

Introduction

Kevin C Wang is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of neurobiology, particularly in understanding and promoting axon regeneration. With a total of 4 patents to his name, Wang's work is pivotal in developing therapeutic strategies for nerve injuries.

Latest Patents

Wang's latest patents include innovative methods for determining the binding between the Nogo receptor and the p75 neurotrophin receptor. His first patent focuses on inhibitors of Nogo Receptor (NgR)-p75 binding, which are utilized to reduce NgR-p75 binding-mediated axon growth inhibition. This method employs mixtures of NgR and p75 in pharmaceutical screens to identify agents that inhibit this binding and promote axon regeneration. Another significant patent addresses reducing myelin-mediated inhibition of axon regeneration. This involves using oligodendrocyte-myelin glycoprotein (OMgp)-specific binding agents to mitigate OMgp-mediated axon growth inhibition. Similar to his first patent, mixtures of axons and OMgp, along with mixtures of NgR and OMgp, are used in pharmaceutical screens to characterize agents that inhibit the binding of NgR to OMgp and encourage axon regeneration.

Career Highlights

Kevin C Wang is currently associated with the Children's Medical Center Corporation, where he continues to advance his research in neurobiology. His work is instrumental in developing new therapeutic approaches for nerve injuries and related conditions.

Collaborations

Wang collaborates with notable colleagues, including Zhigang He and Jieun A Kim, who contribute to his research endeavors and enhance the impact of his innovations.

Conclusion

Kevin C Wang's contributions to neurobiology through his patents and research are vital for advancing treatments for nerve injuries. His innovative approaches hold promise for improving patient outcomes in the field of regenerative medicine.